ArticleJournal of chemical information and modeling2025
Automated Annotation of Sites of Metabolism from Biotransformation Data.
Article in Journal of chemical information and modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metabolite Identification Data in Drug Discovery, Part 2: Site-of-Metabolism Annotation, Analysis, and Exploration for Machine Learning.Molecular pharmaceutics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Computational models predicting the Sites-of-Metabolism (SOMs) of small organic molecules have become invaluable tools for studying and optimizing the metabolic properties of xenobiotics. However, the performance of SOM predictors has shown signs of plateauing in recent years, primarily due to the limited availability of training data. While vast amounts of biotransformation data in the form of substrate-metabolite pairs exist, their potential for SOM prediction remains largely untapped due to the absence of annotations. Annotating SOMs requires expert knowledge and is a highly time-consuming process. To address this challenge, we introduce AutoSOM, the first open-source tool that automatically extracts SOMs by mapping structural differences using transformation rules. AutoSOM is both fast and highly accurate, achieving over 90% labeling accuracy on a diverse validation set of more than 5,000 reactions within minutes. Moreover, its annotation process is fully transparent and interpretable, which we hope will facilitate its adoption in high-stakes downstream applications such as drug discovery campaigns and regulatory assessments. Beyond accelerating annotation, AutoSOM enables standardized and consistent SOM labeling across institutions without requiring direct data sharing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.